pulmonary-embolism

Documents about pulmonary-embolism

• Fatigue after pulmonary embolism — prevalence and predictors / Marie Schmitz, Simone Fischer, Thomas M. Berghaus, Markus Naumann, Jakob Linseisen, Christine Meisinger, Inge Kirchberger#661723Deutsche Nationalbibliothek
• Impact of Associated Infections on the Clinical Course and Risk-Stratification Profile of Pulmonary Embolism: Comparative Analysis Using PESI, Wells, Padua, and IMPROVE Scores.#785683NCBI PubMed Central
• Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease#861702ClinicalTrials.gov
• Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries#915079ClinicalTrials.gov
• Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication#901014ClinicalTrials.gov
• Genotype-Guided Warfarin Therapy Trial#1045528ClinicalTrials.gov
• Characteristics, management, and outcomes of segmental and subsegmental pulmonary embolism in ICU patients: A retrospective cohort study#358741PLOS
• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism#904609ClinicalTrials.gov
• CoMbination of Data From European Cohorts as Part of the European MORPHEUS Project [HORIZON-HLTH-2022-11-01] - "MC-MORPHEUS".#908280ClinicalTrials.gov
• Pulmonary embolism rule-out decision-making tools for patients aged 35 years or younger in hospital emergency departments: a post-hoc analysis of performance in 3 prospective cohorts#129359HAL (France)
• Association between albumin-bilirubin (ALBI) score and all-cause mortality in critically ill patients with pulmonary embolism: a cohort study based on the MIMIC-IV database.#685592NCBI PubMed Central
• NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial#901627ClinicalTrials.gov
• Lower Limb Blood Flow Geko vs Foot Pump#905196ClinicalTrials.gov
• Non-Interruptive Alerts for Improving Use of Clinical Decision Rules#1033403ClinicalTrials.gov
• Thoracic muscle loss increases the use of mechanical ventilation in elderly patients with pulmonary embolism: constructing and validating a machine learning model on a two-center cohort.#749NCBI PubMed Central
• Thromboembolic Complications in Mild Covid-19 Cases#859792ClinicalTrials.gov
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure#981630ClinicalTrials.gov
• A Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound#993765ClinicalTrials.gov
• Persistent Hypoxemia on Home Sleep Apnea Testing Prompting Further Evaluation for Pulmonary Embolism: A Case Report#177633ODU Digital Commons
• Nudging provider adoption of clinical decision support: study protocol for a stepped-wedge cluster randomized, hybrid type III trial of an electronic health record-agnostic pulmonary embolism risk tool.#396185NCBI PubMed Central
• Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon#833291ClinicalTrials.gov
• Retrospective Study of Acute Chest Pain in Extremely Critical Condition for More Than Ten Years#883783ClinicalTrials.gov
• Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO Patients#898239ClinicalTrials.gov
• Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital#810895ClinicalTrials.gov
• BREVOC Study: Exhaled VOCs for High-Risk Chest Pain in the ED#832957ClinicalTrials.gov
• Prospective Multicenter Study for Early Evaluation of Acute Chest Pain#836749ClinicalTrials.gov
• Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence#857638ClinicalTrials.gov
• Optimal Duration of Anticoagulation in Deep Venous Thrombosis#865929ClinicalTrials.gov
• Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients#967991ClinicalTrials.gov
• Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage#979400ClinicalTrials.gov
• Natural History of Isolated Deep Vein Thrombosis of the Calf#858985ClinicalTrials.gov
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE#1009685ClinicalTrials.gov
• D-dimer and lower limb ultrasound as prognostic factors for recurrent deep venous thrombosis and pulmonary embolism: A systematic review and meta-analysis#187814PLOS
• Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease#853387ClinicalTrials.gov
• The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study#807802ClinicalTrials.gov
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management#839687ClinicalTrials.gov
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy#1029956ClinicalTrials.gov
• Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study#918506ClinicalTrials.gov
• Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism#874618ClinicalTrials.gov
• Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian Failure#870770ClinicalTrials.gov
• RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing#807433ClinicalTrials.gov
• Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome#883423ClinicalTrials.gov
• The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)#856379ClinicalTrials.gov
• Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism#847210ClinicalTrials.gov
• Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity#877440ClinicalTrials.gov
• Low skeletal muscle mass predicts 30-day mortality in patients with acute pulmonary embolism: a multicenter study / Alexey Surov, Andreas Wienke, Mattes Hinnerichs, Liv Sticklus, Roman Kloeckner, Malte Sieren, Felix G. Meinel, Justus Hillebrand, Nora Lubina, Claudia Wollny, Tobias Jorg, Maximilian Moos, Jan Borggrefe#783951Deutsche Nationalbibliothek
• Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies#802013ClinicalTrials.gov
• Current Status and Determinants of Care for Patients With Acute Chest Pain in China: A Retrospective Analysis of Data From the China Chest Pain Center Registry#855379ClinicalTrials.gov
• Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients#873715ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).#836651ClinicalTrials.gov